Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cellular mechanisms in inflammatory myopathies

R Hohlfeld1, N Goebels, A G Engel

  • 1Department of Neurology, Ludwig-Maximilians University, Munich, Germany.

Bailliere'S Clinical Neurology
|November 1, 1993
PubMed
Summary

Cell-mediated immunity, particularly cytotoxic T cells, is key in inflammatory myopathies like inclusion body myositis and polymyositis. Research suggests these T cells may target muscle autoantigens, driving disease pathogenesis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correcting gut dysbiosis can ameliorate inflammation and promote remyelination in multiple sclerosis - Commentary.

Multiple sclerosis (Houndmills, Basingstoke, England)·2021
Same author

Myelin-oligodendrocyte-glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degeneration.

Journal of neurology·2016
Same author

[Monitoring of blood parameters under course-modified MS therapy : Substance-specific relevance and current recommendations for action].

Der Nervenarzt·2016
Same author

[Current aspects of therapy conversion for multiple sclerosis].

Der Nervenarzt·2015
Same author

Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment.

The Lancet. Neurology·2015
Same author

[Immunotherapies for multiple sclerosis : review and update].

Der Internist·2015

Area of Science:

  • Immunology
  • Cellular Biology
  • Muscle Physiology

Background:

  • Cell-mediated immune mechanisms are central to inflammatory myopathies such as inclusion body myositis (IBM) and polymyositis (PM).
  • CD8+ cytotoxic T cells expressing alpha/beta receptors invade non-necrotic muscle fibers in IBM and PM, a hallmark of myocytotoxicity.
  • A variant of PM involves CD4-CD8- T cells with gamma/delta receptors invading muscle fibers.

Purpose of the Study:

  • To investigate the role of cell-mediated immunity in IBM and PM.
  • To explore the potential for muscle autoantigens to be recognized by cytotoxic T cells in inflammatory myopathies.
  • To understand the interaction between muscle cells and cytotoxic effector cells in vitro.

Main Methods:

  • Analysis of T cell infiltration and HLA molecule expression in muscle biopsies from IBM and PM patients.
  • In vitro studies using myoblasts and myotubes to assess their interactions with cytotoxic T cells (CD8+ and natural killer cells).
  • Expansion of muscle-derived CD8+ T cells and investigation of their cytotoxic effects on autologous myotubes.

Main Results:

  • Muscle fibers in IBM and PM express HLA class I molecules, suggesting recognition by CD8+ T cells presenting muscle-derived peptides.
  • Cultured myotubes are susceptible to lysis by allogeneic CD8+ T cells and natural killer cells.
  • In vitro studies showed a low but significant autoreactive cytotoxic effect of muscle-derived CD8+ T cells on autologous myotubes.

Conclusions:

  • Cytotoxic T cells likely recognize muscle autoantigens presented on HLA class I molecules in IBM and PM.
  • Myoblasts and myotubes can participate in immune responses, potentially presenting autoantigens to T cells.
  • Identifying specific autoantigens is crucial for understanding the pathogenesis of inflammatory myopathies.

Related Experiment Videos